Lemon verbena (vervain, LV) is used in traditional folk medicine as a remedy against asthma, spasms, cold, fever, pain of different genesis, insomnia, etc., but its effects have not been examined experimentally. We studied effects of an aqueous extract of leafs of this plant on the parameters of nociception-related tests, tail-flick, and writhing ones. The first aqueous extract of LV leafs was prepared and dried. Wistar rats were randomly divided into seven experimental groups, which received i.p. injections of saline (control), LV extract (10, 100, 500, and 1000 mg of dry substance per 1 kg of the body mass), morphine, and 1000 mg/kg of the LV extract + naloxone. Injections of 500 and 1000 mg/kg of the extract significantly increased the tail-flick latency, as compared to that in the control group (P < < 0.001). The number of writhings per one hour decreased after injections of the extract (100-1000 mg/kg). The maximum analgesic effects of the extract were comparable with those of morphine (10 mg/kg). Naloxone completely abolished the effect of the LV extract in the tail-flick test and partly suppressed such action in the writhing test. Thus, our experiments demonstrated noticeable anti-nociceptive effects of the aqueous LV extract; possibilities for application of this extract or its derivatives in pain management should be examined.
INTRODUCTION
Search for effective analgesic agents having minimum side effects is an important task in neuropharmacology and neurophysiology [1, 2] . At present, a number of means (mostly plant-derived) used in traditional folk medicine are subjected to intense research from this aspect. Such studies inevitably include accurate experimental testing of the respective capabilities of the respective remedies and tempts to elucidate biochemical and pharmacological mechanisms of the effects of active constituents of such means.
Lemon verbena (LV, Aloysia citroiodora, Lippia citroiodora Kunth, or Verbena triphylla; there are some other synonyms) is a perennial shrub belonging to the family of Verbenaceae. It is native to South-western America, brought to Europe by the Spanish and Portuguese in the 17th century and cultivated for its oil [3] . It has been traditionally used in folk medicine as a remedy in treatments 1 Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran Correspondence should be addressed to S. Shahidi (e-mail: siamakshahidi@yahoo.com).
of asthma, spasms, cold, fever, flatulence, colic, indigestion, insomnia, anxiety, and headache [4, 5] . Its constituents were demonstrated to exert antioxidant effects [6] [7] [8] . At the same time, the effects of remedies prepared from LV have not been studied experimentally until now. We tried to estimate quantitatively the effects of the aqueous extract of LV in extensively used nociception-related tests, tail-flick and writhing ones, in adult male rats.
METHODS
Preparation of the Extract. Dried LV leafs were bought from the Mehr Giahe Kosar Company (Medicinal Plants Company) in Iran-Shiraz. Leafs were chopped by an electrical grinder; 500 g of the material were soaked into 2.0 l of distilled water for 12 h at room temperature. The extract was filtered through filter paper (Whatman, Cat. No. 1442 125), got dry in a hot air oven (50°C), and turned into powder. The obtained powder was stored in a refrigerator. For injections, the required amounts of dry extract powder were weighed and dissolved in normal saline.
Experimental Groups. Male Wistar rats (180-200 g) were bought from the Pasteur Institute of Iran, housed in groups of three in polypropylene cages with free access to water and food ad libitum, and kept in a room under controlled conditions (24 ± ± 1°C and a 12/12 h light/dark cycle).
The rats were randomly divided into seven experimental groups (n = 8 in each). Animals of the control group received i.p. normal saline (0.5 ml), those of four LV groups were i.p. injected with 10, 100, 500, and 1000 mg/kg of the extract; the morphine group received 10 mg/kg morphine, and the 7th group was injected with 4 mg/kg naloxone + + 1000 mg/kg LV extract.
Evaluation of Anti-Nociceptive Activity. Tail-Flick Test. A standard technique of this test was used. The tail flick latency (TFL) was measured as the time interval between the beginning of application of radiant heat from an infrared stimulator (tail-flick apparatus) to the rat's tail (5-8 cm from the tip) and the moment of tail withdrawal. The intensity of radiant heat was adjusted to establish the TFL value of 2-3 sec. The baseline latency was obtained using the mean of three similar consecutive measurements. To avoid tissue damage, a cut-off time of 10 sec was set [9, 10] .
The measurements were performed before and 20 min after the treatment with normal saline (control group), extract (four experimental groups), or morphine. In the naloxone + LV extract group, the TFL was first measured; then naloxone and, 10 min later, the LV extract were injected i.p., and, finally, the TFL was measured again 20 min later. In all cases, means of three measurements were taken into consideration.
Writhing Test. Thirty minutes after the treatment with saline or LV extract, 1 ml of 1% acetic acid solution was injected i.p. into experimental rats. Then, the animals were placed immediately into a glass box, and the number of abdominal constrictions (writhings) was counted for 1 h. The rats with a decreased number of writhings were considered protected from nociception [11, 12] .
Statistical Analysis. Numerical data in the groups were compared by one-way analysis of variance (ANOVA) followed by the Tukey post-hoc test. The results are expressed below as means ± s.e.m. and P < 0.05 was considered significant in intergroup comparisons.
RESULTS
Tail-Flick Test. There were no significant differences between the TFL values before LV or morphine injections among the experimental groups (F (6,49) = 3.120, P > 0.05). However, the significant between-group differences in the TFL appeared after treatment (F (6,49) = 62.412, P < 0.001). The respective index showed no significant differences after injections of the LV extract in the doses of 10 and 100 mg/kg. The dose 500 mg/kg, however, induced highly significant prolongation of the TLF (P < < 0.001, as compared to the control). At the dose of 1000 mg/kg, the TLF was about three times longer than that in the control (P < 0.001) and nearly equal to that observed after injection of a "standard" opioid analgesic, morphine. Preliminary injection of the opioid receptor antagonist naloxone resulted in practically complete removal of the effect of 1000 mg/kg of the LV extract (P > 0.05 in comparison with the control; Fig. 1) .
Writhing Test. Injections of 100 to 1000 mg/kg of the LV extract provided significant decreases in the number of writhings within the test period (60 min; F (6,49) = 34.361, P < 0.001). At the first of the mentioned doses, the writhing number corresponded to 42% of that in the control (saline) group (P < < 0.001). Greater doses of the extract (500 and 1000 mg/kg) provided nearly complete inhibition of writhing movements induced by visceral pain after acetic acid test injections (P < 0.001 in both cases). Injections of morphine provided nearly the same effect (P < 0.001). The smallest of the extract doses used (10 mg/kg) exerted no significant effect on the results of the writhing test (P > 0.05). Injections of naloxone made before introductions of 1000 mg/kg of the LV extract resulted in significant (P < 0.01) suppression of the analgesic effect of this extract, but this suppression was not complete; the number of writhings during the test period corresponded to 62% of the respective index in the control (Fig. 2) .
The nociceptive effect in the above test is relatively short-lasting and is intensely influenced by agonists of µ-opioid receptors responsible for analgesia in acute pain models. Therefore, it is believed that agents effective in this test exert their influences predominantly through μ-opioid receptors [13, 14] . Our observations show that the analgesic effect of the aqueous LV extract is nearly fully prevented by pretreatment with the opioid antagonist naloxone; thus, in the tail-flick test this extract predominantly affects the opioid system.
The situation is somewhat different in the writhing test. Intraperitoneal administration of acetic acid results in the release of prostaglandins (like PGE2 and PGF2α) and sympathomimetic mediators; their levels are increased in the peritoneal fluid of the acetic acid-injected rat [15] . Abdominal constrictions produced after administration of acetic acid are related to sensitization of nociceptors to prostaglandins [16] . Thus, it is possible that the effect of the LV extract is also based on inhibition of synthesis and/or release of prostaglandins. It was reported that the leaves of LV are rich in flavonoids and aldehydes (in particular, citral and citronellal) [4] . Flavonoids are well-known agents exerting antiinflammatory and analgesic effects; furthermore, their effect on prostaglandins has been proved [17] . It seems probable that a part of the analgesic effect of the LV extract is related to a compound called verbascoside. The latter is a phenylpropanoid glycoside isolated from a few medicinal plants of different families, in particular, those of Verbenaceae, including Lippia citriodora [18] [19] [20] . In previous studies, noticeable anti-inflammatory and analgesic effects of verbascoside have been welldocumented [18] . It has also been reported that the analgesic effect of verbascoside is not prevented by pretreatment with the opioid antagonist naloxone; the effects of verbascoside do not require activation of the opioid system [18] .
Therefore, administration of the aqueous LV extract exerts clearly pronounced dose-dependent analgesic effects in both tail-flick and writhing tests in rats. A part of the analgesic effects of this extract is due to activation of the opioid system. It can be suggested that the extract of LV may be considered a complementary analgesic mean counteracting pain of different geneses. At the same time, it should be noted that significant analgesic effects were provided by rather high doses of the extract. Thus, it seems that further research directed toward isolation of most effective constituents of such extracts is 
DISCUSSION
The results of our study indicated that the aqueous LV extract is capable of exerting rather intense and highly significant antinociceptive effects in both tail-flick and writhing tests. In the former test, acute pain results from activation of high-threshold thermonociceptors localized in the skin of the rat's tail. Results of the writhing test reflect generalized motor reactions induced by transient visceral pain developing after stimulation of visceral chemonociceptors by the acetic acid solution. Both tail-flick and writhing tests are used to detect the actions of central and peripheral analgesics. It should be noted that results of the tail-slick test are more sensitive to centrally acting analgesics.
expedient; this, probably, can help to obtain some effective LV-based means usable in clinics.
